$96.00
-2.27[-2.31%]
At close: Apr 17
$96.00
0[0.00%]
After Hours: 4:00PM EDT
Tenet Healthcare
(NYSE:THC)Tenet Healthcare Stock (NYSE:THC), Analyst Ratings, Price Targets, Predictions
Tenet Healthcare Corp has a consensus price target of $95.83, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from Deutsche Bank, Cantor Fitzgerald, and Wells Fargo on April 12, 2024, April 10, 2024, and March 28, 2024. With an average price target of $115 between Deutsche Bank, Cantor Fitzgerald, and Wells Fargo, there's an implied 19.79% upside for Tenet Healthcare Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Deutsche Bank
Cantor Fitzgerald
Wells Fargo
Wolfe Research
Mizuho
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Tenet Healthcare
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/12/2024 | THC | Buy Now | Tenet Healthcare | $96.00 | 31.25% | Deutsche Bank | Pito Chickering | $100 → $126 | Maintains | Buy | Get Alert |
| 04/10/2024 | THC | Buy Now | Tenet Healthcare | $96.00 | 8.33% | Cantor Fitzgerald | Sarah James | → $104 | Reiterates | Overweight → Overweight | Get Alert |
| 03/28/2024 | THC | Buy Now | Tenet Healthcare | $96.00 | 19.79% | Wells Fargo | Stephen Baxter | $105 → $115 | Maintains | Overweight | Get Alert |
| 03/27/2024 | THC | Buy Now | Tenet Healthcare | $96.00 | 27.08% | Wolfe Research | Justin Lake | → $122 | Upgrade | Peer Perform → Outperform | Get Alert |
| 03/11/2024 | THC | Buy Now | Tenet Healthcare | $96.00 | 14.58% | Mizuho | Ann Hynes | $100 → $110 | Maintains | Buy | Get Alert |
| 03/06/2024 | THC | Buy Now | Tenet Healthcare | $96.00 | 17.71% | Barclays | Andrew Mok | → $113 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | THC | Buy Now | Tenet Healthcare | $96.00 | 8.33% | Cantor Fitzgerald | Sarah James | → $104 | Reiterates | Overweight → Overweight | Get Alert |
| 02/15/2024 | THC | Buy Now | Tenet Healthcare | $96.00 | 9.38% | Wells Fargo | Stephen Baxter | $98 → $105 | Maintains | Overweight | Get Alert |
| 02/09/2024 | THC | Buy Now | Tenet Healthcare | $96.00 | 9.38% | Truist Securities | David Macdonald | $92 → $105 | Maintains | Buy | Get Alert |
| 02/09/2024 | THC | Buy Now | Tenet Healthcare | $96.00 | 13.54% | RBC Capital | Ben Hendrix | $97 → $109 | Maintains | Outperform | Get Alert |
| 02/09/2024 | THC | Buy Now | Tenet Healthcare | $96.00 | 4.17% | Mizuho | Ann Hynes | $90 → $100 | Maintains | Buy | Get Alert |
| 02/09/2024 | THC | Buy Now | Tenet Healthcare | $96.00 | 8.33% | Cantor Fitzgerald | Sarah James | $94 → $104 | Maintains | Overweight | Get Alert |
| 11/20/2023 | THC | Buy Now | Tenet Healthcare | $96.00 | -4.17% | Truist Securities | David Macdonald | → $92 | Reiterates | Buy → Buy | Get Alert |
| 11/17/2023 | THC | Buy Now | Tenet Healthcare | $96.00 | -15.63% | JP Morgan | Calvin Sternick | $91 → $81 | Maintains | Overweight | Get Alert |
| 11/14/2023 | THC | Buy Now | Tenet Healthcare | $96.00 | -11.46% | Jefferies | Brian Tanquilut | $95 → $85 | Maintains | Buy | Get Alert |
| 11/09/2023 | THC | Buy Now | Tenet Healthcare | $96.00 | -11.46% | Goldman Sachs | Jamie Perse | $98 → $85 | Maintains | Buy | Get Alert |
| 11/02/2023 | THC | Buy Now | Tenet Healthcare | $96.00 | -2.08% | UBS | Andrew Mok | $104 → $94 | Maintains | Buy | Get Alert |
| 11/01/2023 | THC | Buy Now | Tenet Healthcare | $96.00 | -6.25% | Raymond James | John Ransom | $95 → $90 | Maintains | Strong Buy | Get Alert |
| 10/31/2023 | THC | Buy Now | Tenet Healthcare | $96.00 | -19.79% | Mizuho | Ann Hynes | $94 → $77 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Tenet Healthcare (THC)?
The latest price target for Tenet Healthcare (NYSE: THC) was reported by Deutsche Bank on April 12, 2024. The analyst firm set a price target for $126.00 expecting THC to rise to within 12 months (a possible 31.25% upside). 41 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tenet Healthcare (THC)?
The latest analyst rating for Tenet Healthcare (NYSE: THC) was provided by Deutsche Bank, and Tenet Healthcare maintained their buy rating.
When was the last upgrade for Tenet Healthcare (THC)?
The last upgrade for Tenet Healthcare Corp happened on March 27, 2024 when Wolfe Research raised their price target to $122. Wolfe Research previously had a peer perform for Tenet Healthcare Corp.
When was the last downgrade for Tenet Healthcare (THC)?
There is no last downgrade for Tenet Healthcare.
When is the next analyst rating going to be posted or updated for Tenet Healthcare (THC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenet Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenet Healthcare was filed on April 12, 2024 so you should expect the next rating to be made available sometime around April 12, 2025.
Is the Analyst Rating Tenet Healthcare (THC) correct?
While ratings are subjective and will change, the latest Tenet Healthcare (THC) rating was a maintained with a price target of $100.00 to $126.00. The current price Tenet Healthcare (THC) is trading at is $96.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.